Treatment of large-vessel vasculitis (LVV) remains challenging. Patients usually respond to glucocorticoid (GC) therapy, but often relapse on tapering of the GC dose or after GC withdrawal. In addition, GCs are fraught with numerous adverse events. The aim of this study was to assess the efficacy and safety of the anti-IL-6 receptor (IL-6R) antibody tocilizumab (TCZ) in patients with LVV
Giant cell arteritis and Takayasu arteritis are the two major forms of idiopathic large vessel vascu...
Susan Patricia Mollan,1,2 John Horsburgh,1 Bhaskar Dasgupta3 1Birmingham Neuro-Ophthalmology Unit, U...
Anti-TNF-α therapy has successfully been used to treat Takayasu arteritis (TA) refractory to convent...
Treatment of large-vessel vasculitis (LVV) remains challenging. Patients usually respond to glucocor...
Glucocorticoids (GC) are the mainstay of treatment of large-vessel vasculitis (LVV), but a sizeable ...
Glucocorticoids (GC) are the mainstay of treatment of large-vessel vasculitis (LVV), but a sizeable ...
OBJECTIVE: To evaluate the effect of IL-6 blockade using tocilizumab in inducing remission of arteri...
Giant cell arteritis is a granulomatous immune-mediated vasculitis of medium and large vessels. It m...
Giant cell arteritis (GCA) is the most frequent type of vasculitis, occurring in people older than 5...
BACKGROUND: Giant-cell arteritis commonly relapses when glucocorticoids are tapered, and the prolong...
<div><p>Background</p><p><u>G</u>iant <u>c</u>ell <u>a</u>rteritis (GCA) and <u>Ta</u>kayasu's <u>a<...
Purpose: While glucocorticoids (GCs) are effective in large vessel vasculitis (LVV), they may cause ...
The efficacy and safety of tocilizumab (TCZ), an IL-6 receptor-alpha inhibitor, was evaluated in pat...
The efficacy and safety of tocilizumab (TCZ), an IL-6 receptor-alpha inhibitor, was evaluated in pat...
Anti-TNF-α therapy has successfully been used to treat Takayasu arteritis (TA) refractory to convent...
Giant cell arteritis and Takayasu arteritis are the two major forms of idiopathic large vessel vascu...
Susan Patricia Mollan,1,2 John Horsburgh,1 Bhaskar Dasgupta3 1Birmingham Neuro-Ophthalmology Unit, U...
Anti-TNF-α therapy has successfully been used to treat Takayasu arteritis (TA) refractory to convent...
Treatment of large-vessel vasculitis (LVV) remains challenging. Patients usually respond to glucocor...
Glucocorticoids (GC) are the mainstay of treatment of large-vessel vasculitis (LVV), but a sizeable ...
Glucocorticoids (GC) are the mainstay of treatment of large-vessel vasculitis (LVV), but a sizeable ...
OBJECTIVE: To evaluate the effect of IL-6 blockade using tocilizumab in inducing remission of arteri...
Giant cell arteritis is a granulomatous immune-mediated vasculitis of medium and large vessels. It m...
Giant cell arteritis (GCA) is the most frequent type of vasculitis, occurring in people older than 5...
BACKGROUND: Giant-cell arteritis commonly relapses when glucocorticoids are tapered, and the prolong...
<div><p>Background</p><p><u>G</u>iant <u>c</u>ell <u>a</u>rteritis (GCA) and <u>Ta</u>kayasu's <u>a<...
Purpose: While glucocorticoids (GCs) are effective in large vessel vasculitis (LVV), they may cause ...
The efficacy and safety of tocilizumab (TCZ), an IL-6 receptor-alpha inhibitor, was evaluated in pat...
The efficacy and safety of tocilizumab (TCZ), an IL-6 receptor-alpha inhibitor, was evaluated in pat...
Anti-TNF-α therapy has successfully been used to treat Takayasu arteritis (TA) refractory to convent...
Giant cell arteritis and Takayasu arteritis are the two major forms of idiopathic large vessel vascu...
Susan Patricia Mollan,1,2 John Horsburgh,1 Bhaskar Dasgupta3 1Birmingham Neuro-Ophthalmology Unit, U...
Anti-TNF-α therapy has successfully been used to treat Takayasu arteritis (TA) refractory to convent...